ceRNA(竞争性内源RNA):国自然基金热点领域

2015-12-03 MedSci MedSci原创

RNA家族,一直是研究热点,从当年的siRNA,miRNA, piRNA,到LncRNA,都是明星。如今又有一些新的名词出现,如ncRNA(lncRNA & circRNA & piRNA) , ceRNA,  其实ceRNA,并不是新的RNA分子,只是一种最新发现的调节机制。 ceRNA(competing endogenous RNAs)假说揭示了一

RNA家族,一直是研究热点,从当年的siRNA,miRNA, piRNA,到LncRNA,都是明星。如今又有一些新的名词出现,如ncRNA(lncRNA & circRNA & piRNA) , ceRNA, 

其实ceRNA,并不是新的RNA分子,只是一种最新发现的调节机制。

ceRNA(competing endogenous RNAs,竞争性内源RNA)假说揭示了一种RNA间相互作用的新机制。已知microRNA可以通过结合mRNA导致基因沉默,而ceRNA可以通过竞争性地结合microRNA来调节基因表达。ceRNA可以通过应答元件(microRNA response elements,MREs)与microRNA结合从而影响microRNA导致的基因沉默,这揭示了一条RNA->microRNA调节通路的存在,具有重大生物意义


ceRNA代表一种全新的基因表达调控模式,比起miRNA调控网络,ceRNA调控网络更为精细和复杂,涉及更多RNA分子,包括mRNA、假基因、长链非编码RNA和miRNA等。

2011年,Pandolfi等人在“A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?”这篇文章中,Pandolfi等人提出了一种关于信使RNAs如何转录假基因,以及长链非编码RNAs如何相互“交流”的新假说,这些进一步的研究将有助于癌症等疾病的分子机理的解析。Pandolfi等人提出了ceRNA(competing endogenous RNA,竞争性内源RNA)的假说,认为这种ceRNA活性能形成一种大规模转录调控网络,可以扩大人类基因组中的功能性遗传信息。他们认为这种活性通过miRNAs应答元件,可以作为mRNAs转录假基因,以及长链非编码RNAs相互“交流”的新语言。Pandolfi等人也认为ceRNA活性也在病理条件,比如癌症中扮演了重要角色,因此对于解开一些癌症研究之谜具有重要意义。

1. 资助情况

从2013-2015年,标题中含有ceRNA的标书数量基本持平。而2016年的中标数量比2015年翻了一倍。资助额度的变化趋势接近。我们注意到2014年总资助额度较高,发现当年有一个200万的大项目,主要研究肿瘤基于ceRNA机制的长链非编码RNA调控网络。


2. 领域分析

就像lncRNA为主题的标书肿瘤研究的最大赢家,ceRNA为主题的标书也有同样的趋势。


在肿瘤研究领域中,是热点,但基本都还是老话题,如肿瘤侵袭与转移为主,有一些涉及到肿瘤干细胞等肿瘤的新兴领域,预计2016年主题会更新颖与深入。

3. 标题分析

3.1 经典的LncRNA作为ceRNA调控方式,简短,但并不明确

  1. ceRNA介导的多层次调控网络功能研究及其在线分析平台构建
  2. Laptm5作为ceRNA在小鼠B细胞淋巴瘤中的作用机制研究

公式:某分子作为ceRNA在某肿瘤中的作用机制

3.2 中规中矩式

  1. 长链非编码RNA NR024122作为ceRNA在低氧性肺动脉高压发病中的作用和机制研究 

公式:某分子作为ceRNA通过某个已经明确的分子在某疾病中的调节机制

3.3 复杂,明确的结论式

样式:某分子作为ceRNA通过某个已经明确的分子和某个机制在某肿瘤中的调节

4. 2016年申报展望

总结起来,ceRNA是新星,备受瞩目。新,意味着吸引眼球,也意味着更多未知。

相关研究资源:

LncRNA的作用机制不清楚,lncRNA的功能非常难研究。当前很多通过研究miRNA与lncRNA的调控关系来揭示非编码RNA的功能,最热门的要数ceRNA调控网络。相关的可利用资源包括

(1)starBase平台(http://starbase.sysu.edu.cn/mirLncRNA.php) 构建了最全面的CLIP-Seq实验支持的miRNA和lncRNA的调控关系网络,包括构建了ceRNA调控网络尽管microRNAs(miRNAs),其他的非编码RNAs(non-coding RNAs,ncRNAs(例如lncRNAs,假基因和circRNAs(circular RNAs,循环RNAs))和竞争性内源RNAs(competing endogenous RNAs,ceRNAs)涉及到细胞命运决定和各种人类疾病,然而令人惊讶地,对多种类型RNAs间的调控相互作用网络知之甚少。本研究中,我们开发了starBase v2.0(http://starbase.sysu.edu.cn/)以从由37项独立研究产生的108套CLIP-Seq(PAR-CLIP、HITS-CLIP、iCLIP、CLASH)数据集中系统地鉴定RNA-RNA和蛋白质-RNA相互作用网络。通过分析数百万个RNA结合蛋白的结合位点,迄今为止,我们鉴定了约9000对miRNA-circRNA、16,000对miRNA-假基因和285,000对miRNA-mRNA和miRNA-lncRNA相互作用网络。我们从CLIP支持的miRNA靶位点中鉴定了约10,000个ceRNA对。通过结合13种功能基因组注释,我们开发了miRFunction和ceRNAFunction网络服务器以从miRNA介导的调控网络中预测miRNA和其他ncRNA的功能(http://starbase.sysu.edu.cn/mrnaCeRNA.php

(2)DIANA-LncBase数据库(www.microrna.gr/LncBase)构建了基于单个CLIP-Seq数据的miRNA和lncRNA调控关系。

(3)lnCeDB:充当竞争性内源RNA的人类长链非编码RNA数据库

长链非编码RNA(long noncoding RNA,lncRNA)通过干扰microRNA(miRNA)通路,充当竞争性内源RNA(ceRNA)影响转录后调控。这些lncRNAs中有miRNA响应元件(miRNA responsive elements,MRE),并控制与它们的靶mRNAs结合的可用内源性miRNAs,因此减少这些mRNAs的抑制。lnCeDB提供了一个能够潜在地充当ceRNAs的人类lncRNAs数据库(来自GENCODE 19版)。分别从TargetScan和StarBase中收集了人类miRNAs推断的mRNA靶和比对到AGO剪裁区的靶。从miRCode数据库中下载了人类miRNAs的lncRNA靶(更新至GENCODE 11)。通过我们的找到种子匹配靶位点算法预测了靶向剩余GENCODE 19 lncRNAs的miRNA。这些推断的miRNA-lncRNA相互作用被比对到lncRNAs中的Ago相互作用区。为了找出一个lncRNA-mRNA对真正成为ceRNA的可能性,我们求助于两种方法。第一,从ceRNA对间共享的MREs数与个别候选基因的MREs总数比中计算了一个ceRNA值。第二,通过使用ceRNA对间共享的miRNAs数针对个别RNAs相互作用的miRNAs数的超几何检验确定了每个ceRNA对的P值。典型地,在被公共miRNA(s)靶向的一对RNAs中,应该有一个表达关联,因此增加一个ceRNA的水平导致其他ceRNA水平的增加。几乎等摩尔的竞争性RNAs浓度与更加深刻的ceRNA效果关联。在InCeDB中,人们不仅能够浏览被共同miRNAs靶向的lncRNA-mRNA对,而且能够比较22种人类组织中的lncRNA-mRNA对的表达以估计该对真正成为ceRNAs的几率。可用性:从http://gyanxet-beta.com/lncedb/免费下载。

(4)竞争性内源RNA数据库ceRDB

一个给定mRNA能够通过与miRNAs相互作用而被调节,反过来这些miRNAs的有效性能够通过它们与另外mRNAs的相互作用而被调节。一个给定mRNA利用与miRNAs相互作用的功效,通过共享的miRNA响应元件(miRNA response elements,MREs)被另外的mRNA(竞争性内源mRNA)调控的概念正成为一种基础遗传调控机制。mRNA-mRNA交互的分子基础是通过miRNA响应元件,它们能够基于分子相互作用和进化保守型进行预测。通过研究miRNA响应元件在全基因组mRNA中的同现性,我们为被miRNAs靶向的特异mRNA预测了竞争性内源RNA。与最近发表的工作中预测的调控PTEN的mRNAs相比,表明竞争性内源RNA数据库(ceRDB)中呈现的结果具有生物相关性。可用性:http://www.oncomir.umn.edu/cefinder/

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (14)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2008716, encodeId=e9322008e162a, content=<a href='/topic/show?id=db6969548d' target=_blank style='color:#2F92EE;'>#eRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6954, encryptionId=db6969548d, topicName=eRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Fri Apr 29 08:02:00 CST 2016, time=2016-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999114, encodeId=f548199911416, content=<a href='/topic/show?id=8c65e564367' target=_blank style='color:#2F92EE;'>#竞争性内源RNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75643, encryptionId=8c65e564367, topicName=竞争性内源RNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e43278, createdName=yangjxjc, createdTime=Mon Jun 13 11:02:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49628, encodeId=033a49628dd, content=很值得好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Dec 27 20:39:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49080, encodeId=a22749080b2, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 09:02:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49081, encodeId=e6d9490817e, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 09:02:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44855, encodeId=c021448557a, content=玩不起, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Sat Dec 05 12:37:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521806, encodeId=828a152180620, content=<a href='/topic/show?id=7b9445054f' target=_blank style='color:#2F92EE;'>#ceRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4505, encryptionId=7b9445054f, topicName=ceRNA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e16111401001, createdName=gjsgj, createdTime=Sat Dec 05 06:02:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44718, encodeId=937d44e1862, content=太好了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8681634464, createdName=shenyifeiyang, createdTime=Fri Dec 04 09:14:00 CST 2015, time=2015-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44715, encodeId=b23c44e15f8, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bd011656806, createdName=wumwuy, createdTime=Fri Dec 04 08:35:00 CST 2015, time=2015-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44668, encodeId=bb3044668c1, content=挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Fri Dec 04 00:51:00 CST 2015, time=2015-12-04, status=1, ipAttribution=)]
    2016-04-29 般若傻瓜
  2. [GetPortalCommentsPageByObjectIdResponse(id=2008716, encodeId=e9322008e162a, content=<a href='/topic/show?id=db6969548d' target=_blank style='color:#2F92EE;'>#eRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6954, encryptionId=db6969548d, topicName=eRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Fri Apr 29 08:02:00 CST 2016, time=2016-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999114, encodeId=f548199911416, content=<a href='/topic/show?id=8c65e564367' target=_blank style='color:#2F92EE;'>#竞争性内源RNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75643, encryptionId=8c65e564367, topicName=竞争性内源RNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e43278, createdName=yangjxjc, createdTime=Mon Jun 13 11:02:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49628, encodeId=033a49628dd, content=很值得好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Dec 27 20:39:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49080, encodeId=a22749080b2, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 09:02:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49081, encodeId=e6d9490817e, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 09:02:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44855, encodeId=c021448557a, content=玩不起, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Sat Dec 05 12:37:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521806, encodeId=828a152180620, content=<a href='/topic/show?id=7b9445054f' target=_blank style='color:#2F92EE;'>#ceRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4505, encryptionId=7b9445054f, topicName=ceRNA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e16111401001, createdName=gjsgj, createdTime=Sat Dec 05 06:02:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44718, encodeId=937d44e1862, content=太好了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8681634464, createdName=shenyifeiyang, createdTime=Fri Dec 04 09:14:00 CST 2015, time=2015-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44715, encodeId=b23c44e15f8, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bd011656806, createdName=wumwuy, createdTime=Fri Dec 04 08:35:00 CST 2015, time=2015-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44668, encodeId=bb3044668c1, content=挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Fri Dec 04 00:51:00 CST 2015, time=2015-12-04, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2008716, encodeId=e9322008e162a, content=<a href='/topic/show?id=db6969548d' target=_blank style='color:#2F92EE;'>#eRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6954, encryptionId=db6969548d, topicName=eRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Fri Apr 29 08:02:00 CST 2016, time=2016-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999114, encodeId=f548199911416, content=<a href='/topic/show?id=8c65e564367' target=_blank style='color:#2F92EE;'>#竞争性内源RNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75643, encryptionId=8c65e564367, topicName=竞争性内源RNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e43278, createdName=yangjxjc, createdTime=Mon Jun 13 11:02:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49628, encodeId=033a49628dd, content=很值得好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Dec 27 20:39:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49080, encodeId=a22749080b2, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 09:02:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49081, encodeId=e6d9490817e, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 09:02:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44855, encodeId=c021448557a, content=玩不起, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Sat Dec 05 12:37:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521806, encodeId=828a152180620, content=<a href='/topic/show?id=7b9445054f' target=_blank style='color:#2F92EE;'>#ceRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4505, encryptionId=7b9445054f, topicName=ceRNA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e16111401001, createdName=gjsgj, createdTime=Sat Dec 05 06:02:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44718, encodeId=937d44e1862, content=太好了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8681634464, createdName=shenyifeiyang, createdTime=Fri Dec 04 09:14:00 CST 2015, time=2015-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44715, encodeId=b23c44e15f8, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bd011656806, createdName=wumwuy, createdTime=Fri Dec 04 08:35:00 CST 2015, time=2015-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44668, encodeId=bb3044668c1, content=挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Fri Dec 04 00:51:00 CST 2015, time=2015-12-04, status=1, ipAttribution=)]
    2015-12-27 忠诚向上

    很值得好学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2008716, encodeId=e9322008e162a, content=<a href='/topic/show?id=db6969548d' target=_blank style='color:#2F92EE;'>#eRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6954, encryptionId=db6969548d, topicName=eRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Fri Apr 29 08:02:00 CST 2016, time=2016-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999114, encodeId=f548199911416, content=<a href='/topic/show?id=8c65e564367' target=_blank style='color:#2F92EE;'>#竞争性内源RNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75643, encryptionId=8c65e564367, topicName=竞争性内源RNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e43278, createdName=yangjxjc, createdTime=Mon Jun 13 11:02:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49628, encodeId=033a49628dd, content=很值得好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Dec 27 20:39:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49080, encodeId=a22749080b2, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 09:02:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49081, encodeId=e6d9490817e, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 09:02:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44855, encodeId=c021448557a, content=玩不起, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Sat Dec 05 12:37:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521806, encodeId=828a152180620, content=<a href='/topic/show?id=7b9445054f' target=_blank style='color:#2F92EE;'>#ceRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4505, encryptionId=7b9445054f, topicName=ceRNA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e16111401001, createdName=gjsgj, createdTime=Sat Dec 05 06:02:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44718, encodeId=937d44e1862, content=太好了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8681634464, createdName=shenyifeiyang, createdTime=Fri Dec 04 09:14:00 CST 2015, time=2015-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44715, encodeId=b23c44e15f8, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bd011656806, createdName=wumwuy, createdTime=Fri Dec 04 08:35:00 CST 2015, time=2015-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44668, encodeId=bb3044668c1, content=挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Fri Dec 04 00:51:00 CST 2015, time=2015-12-04, status=1, ipAttribution=)]
    2015-12-27 hixiaoluo

    好文章,值得收藏

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2008716, encodeId=e9322008e162a, content=<a href='/topic/show?id=db6969548d' target=_blank style='color:#2F92EE;'>#eRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6954, encryptionId=db6969548d, topicName=eRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Fri Apr 29 08:02:00 CST 2016, time=2016-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999114, encodeId=f548199911416, content=<a href='/topic/show?id=8c65e564367' target=_blank style='color:#2F92EE;'>#竞争性内源RNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75643, encryptionId=8c65e564367, topicName=竞争性内源RNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e43278, createdName=yangjxjc, createdTime=Mon Jun 13 11:02:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49628, encodeId=033a49628dd, content=很值得好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Dec 27 20:39:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49080, encodeId=a22749080b2, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 09:02:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49081, encodeId=e6d9490817e, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 09:02:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44855, encodeId=c021448557a, content=玩不起, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Sat Dec 05 12:37:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521806, encodeId=828a152180620, content=<a href='/topic/show?id=7b9445054f' target=_blank style='color:#2F92EE;'>#ceRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4505, encryptionId=7b9445054f, topicName=ceRNA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e16111401001, createdName=gjsgj, createdTime=Sat Dec 05 06:02:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44718, encodeId=937d44e1862, content=太好了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8681634464, createdName=shenyifeiyang, createdTime=Fri Dec 04 09:14:00 CST 2015, time=2015-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44715, encodeId=b23c44e15f8, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bd011656806, createdName=wumwuy, createdTime=Fri Dec 04 08:35:00 CST 2015, time=2015-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44668, encodeId=bb3044668c1, content=挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Fri Dec 04 00:51:00 CST 2015, time=2015-12-04, status=1, ipAttribution=)]
    2015-12-27 hixiaoluo

    好文章,值得收藏

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2008716, encodeId=e9322008e162a, content=<a href='/topic/show?id=db6969548d' target=_blank style='color:#2F92EE;'>#eRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6954, encryptionId=db6969548d, topicName=eRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Fri Apr 29 08:02:00 CST 2016, time=2016-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999114, encodeId=f548199911416, content=<a href='/topic/show?id=8c65e564367' target=_blank style='color:#2F92EE;'>#竞争性内源RNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75643, encryptionId=8c65e564367, topicName=竞争性内源RNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e43278, createdName=yangjxjc, createdTime=Mon Jun 13 11:02:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49628, encodeId=033a49628dd, content=很值得好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Dec 27 20:39:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49080, encodeId=a22749080b2, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 09:02:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49081, encodeId=e6d9490817e, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 09:02:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44855, encodeId=c021448557a, content=玩不起, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Sat Dec 05 12:37:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521806, encodeId=828a152180620, content=<a href='/topic/show?id=7b9445054f' target=_blank style='color:#2F92EE;'>#ceRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4505, encryptionId=7b9445054f, topicName=ceRNA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e16111401001, createdName=gjsgj, createdTime=Sat Dec 05 06:02:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44718, encodeId=937d44e1862, content=太好了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8681634464, createdName=shenyifeiyang, createdTime=Fri Dec 04 09:14:00 CST 2015, time=2015-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44715, encodeId=b23c44e15f8, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bd011656806, createdName=wumwuy, createdTime=Fri Dec 04 08:35:00 CST 2015, time=2015-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44668, encodeId=bb3044668c1, content=挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Fri Dec 04 00:51:00 CST 2015, time=2015-12-04, status=1, ipAttribution=)]
    2015-12-05 huangwukui

    玩不起

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=2008716, encodeId=e9322008e162a, content=<a href='/topic/show?id=db6969548d' target=_blank style='color:#2F92EE;'>#eRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6954, encryptionId=db6969548d, topicName=eRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Fri Apr 29 08:02:00 CST 2016, time=2016-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999114, encodeId=f548199911416, content=<a href='/topic/show?id=8c65e564367' target=_blank style='color:#2F92EE;'>#竞争性内源RNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75643, encryptionId=8c65e564367, topicName=竞争性内源RNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e43278, createdName=yangjxjc, createdTime=Mon Jun 13 11:02:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49628, encodeId=033a49628dd, content=很值得好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Dec 27 20:39:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49080, encodeId=a22749080b2, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 09:02:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49081, encodeId=e6d9490817e, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 09:02:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44855, encodeId=c021448557a, content=玩不起, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Sat Dec 05 12:37:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521806, encodeId=828a152180620, content=<a href='/topic/show?id=7b9445054f' target=_blank style='color:#2F92EE;'>#ceRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4505, encryptionId=7b9445054f, topicName=ceRNA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e16111401001, createdName=gjsgj, createdTime=Sat Dec 05 06:02:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44718, encodeId=937d44e1862, content=太好了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8681634464, createdName=shenyifeiyang, createdTime=Fri Dec 04 09:14:00 CST 2015, time=2015-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44715, encodeId=b23c44e15f8, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bd011656806, createdName=wumwuy, createdTime=Fri Dec 04 08:35:00 CST 2015, time=2015-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44668, encodeId=bb3044668c1, content=挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Fri Dec 04 00:51:00 CST 2015, time=2015-12-04, status=1, ipAttribution=)]
    2015-12-05 gjsgj
  8. [GetPortalCommentsPageByObjectIdResponse(id=2008716, encodeId=e9322008e162a, content=<a href='/topic/show?id=db6969548d' target=_blank style='color:#2F92EE;'>#eRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6954, encryptionId=db6969548d, topicName=eRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Fri Apr 29 08:02:00 CST 2016, time=2016-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999114, encodeId=f548199911416, content=<a href='/topic/show?id=8c65e564367' target=_blank style='color:#2F92EE;'>#竞争性内源RNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75643, encryptionId=8c65e564367, topicName=竞争性内源RNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e43278, createdName=yangjxjc, createdTime=Mon Jun 13 11:02:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49628, encodeId=033a49628dd, content=很值得好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Dec 27 20:39:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49080, encodeId=a22749080b2, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 09:02:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49081, encodeId=e6d9490817e, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 09:02:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44855, encodeId=c021448557a, content=玩不起, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Sat Dec 05 12:37:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521806, encodeId=828a152180620, content=<a href='/topic/show?id=7b9445054f' target=_blank style='color:#2F92EE;'>#ceRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4505, encryptionId=7b9445054f, topicName=ceRNA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e16111401001, createdName=gjsgj, createdTime=Sat Dec 05 06:02:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44718, encodeId=937d44e1862, content=太好了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8681634464, createdName=shenyifeiyang, createdTime=Fri Dec 04 09:14:00 CST 2015, time=2015-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44715, encodeId=b23c44e15f8, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bd011656806, createdName=wumwuy, createdTime=Fri Dec 04 08:35:00 CST 2015, time=2015-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44668, encodeId=bb3044668c1, content=挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Fri Dec 04 00:51:00 CST 2015, time=2015-12-04, status=1, ipAttribution=)]
    2015-12-04 shenyifeiyang

    太好了!

    0

  9. [GetPortalCommentsPageByObjectIdResponse(id=2008716, encodeId=e9322008e162a, content=<a href='/topic/show?id=db6969548d' target=_blank style='color:#2F92EE;'>#eRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6954, encryptionId=db6969548d, topicName=eRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Fri Apr 29 08:02:00 CST 2016, time=2016-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999114, encodeId=f548199911416, content=<a href='/topic/show?id=8c65e564367' target=_blank style='color:#2F92EE;'>#竞争性内源RNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75643, encryptionId=8c65e564367, topicName=竞争性内源RNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e43278, createdName=yangjxjc, createdTime=Mon Jun 13 11:02:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49628, encodeId=033a49628dd, content=很值得好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Dec 27 20:39:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49080, encodeId=a22749080b2, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 09:02:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49081, encodeId=e6d9490817e, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 09:02:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44855, encodeId=c021448557a, content=玩不起, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Sat Dec 05 12:37:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521806, encodeId=828a152180620, content=<a href='/topic/show?id=7b9445054f' target=_blank style='color:#2F92EE;'>#ceRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4505, encryptionId=7b9445054f, topicName=ceRNA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e16111401001, createdName=gjsgj, createdTime=Sat Dec 05 06:02:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44718, encodeId=937d44e1862, content=太好了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8681634464, createdName=shenyifeiyang, createdTime=Fri Dec 04 09:14:00 CST 2015, time=2015-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44715, encodeId=b23c44e15f8, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bd011656806, createdName=wumwuy, createdTime=Fri Dec 04 08:35:00 CST 2015, time=2015-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44668, encodeId=bb3044668c1, content=挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Fri Dec 04 00:51:00 CST 2015, time=2015-12-04, status=1, ipAttribution=)]
    2015-12-04 wumwuy

    厉害

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2008716, encodeId=e9322008e162a, content=<a href='/topic/show?id=db6969548d' target=_blank style='color:#2F92EE;'>#eRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=6954, encryptionId=db6969548d, topicName=eRNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ad9f79, createdName=般若傻瓜, createdTime=Fri Apr 29 08:02:00 CST 2016, time=2016-04-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1999114, encodeId=f548199911416, content=<a href='/topic/show?id=8c65e564367' target=_blank style='color:#2F92EE;'>#竞争性内源RNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75643, encryptionId=8c65e564367, topicName=竞争性内源RNA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6e43278, createdName=yangjxjc, createdTime=Mon Jun 13 11:02:00 CST 2016, time=2016-06-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49628, encodeId=033a49628dd, content=很值得好学习, beContent=null, objectType=article, channel=null, level=null, likeNumber=189, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45101626056, createdName=忠诚向上, createdTime=Sun Dec 27 20:39:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49080, encodeId=a22749080b2, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=127, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 09:02:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=49081, encodeId=e6d9490817e, content=好文章,值得收藏, beContent=null, objectType=article, channel=null, level=null, likeNumber=128, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc301610909, createdName=hixiaoluo, createdTime=Sun Dec 27 09:02:00 CST 2015, time=2015-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44855, encodeId=c021448557a, content=玩不起, beContent=null, objectType=article, channel=null, level=null, likeNumber=117, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=90ea1614944, createdName=huangwukui, createdTime=Sat Dec 05 12:37:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1521806, encodeId=828a152180620, content=<a href='/topic/show?id=7b9445054f' target=_blank style='color:#2F92EE;'>#ceRNA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4505, encryptionId=7b9445054f, topicName=ceRNA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e16111401001, createdName=gjsgj, createdTime=Sat Dec 05 06:02:00 CST 2015, time=2015-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44718, encodeId=937d44e1862, content=太好了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=131, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8681634464, createdName=shenyifeiyang, createdTime=Fri Dec 04 09:14:00 CST 2015, time=2015-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44715, encodeId=b23c44e15f8, content=厉害, beContent=null, objectType=article, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bd011656806, createdName=wumwuy, createdTime=Fri Dec 04 08:35:00 CST 2015, time=2015-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=44668, encodeId=bb3044668c1, content=挺好, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150830/IMG55E294026A9942981.jpg, createdBy=fa351627501, createdName=惜言, createdTime=Fri Dec 04 00:51:00 CST 2015, time=2015-12-04, status=1, ipAttribution=)]
    2015-12-04 惜言

    挺好

    0

相关资讯

女性肿瘤预防基金聚力公益 为乳腺癌高危人群保驾护航

同济-宜朗乳腺肿瘤预防门诊爱心援助仪式 16日召开的首都国际癌症论坛上,中国抗癌协会秘书长王瑛说,据2012年癌症有关报告显示,我国每年新发癌症病例约337万,死亡约211万。男性当中肺癌发病率最高,女性是乳腺癌。乳腺癌已经成为威胁女性健康的“头号杀手”,恰逢10月份是世界乳腺癌防治月,乳腺癌再度成为公众关注的焦点。 近日,有媒体报道称苏州有一位叫周雪玮的女士,因为不想给家里添加经

自然科学基金委主任杨卫谈2015年基金工作

近日,国家自然科学基金委(以下简称基金委)在京召开七届三次全委会。第七届全委会委员出席会议,第四届监督委员会委员全程列席会议。作为一年一度的重大会议,在工作报告中,基金委主任、中国科学院院士杨卫也对2014年的基金工作重大进展、2015年基金委开展的各项工作进行了详细解读。持续完善科学基金体制机制过去的一年是全面深化改革部署的一年。在完善科学基金体制机制方面,基金委作出了很多努力。杨卫在报告中

话中有话,如何读懂国自然基金评委的背后暗语?

常见评语1、研究基础差,没有相关的实验结果。点评:与本子相关内容,需要有部分实验结果。2、没有SCI(没有SCI的,国青基本上没有希望)。点评:最好有一两篇一作的SCI后再报国青;至于面上,我们的建议是本子相关内容的,一作或者通讯不少于三篇,最好有三分以上的,这是最低配置。3、有些NSFC本子不像一个项目,而是为一个实验,或一篇文章而打造的。点评:借鉴别人的本子,或找NSFC中标的熟人参谋一下

2015年度国自然基金结果分析统计,整体中标数量趋稳(MedSci**发布)

2015年国家自然科学基金申请项目的评审结果已公布了评审结果。MedSci为大家提供了查询系统——手机版:http://m.medsci.cn/nsfc.do PC版:http://www.medsci.cn/sci/nsfc.do;MedSci提供强大的分析方法,让你了解热点,下面列少数例子给大家分享。历年基金项目分布状况从这里可以看出,自从2012基金总数量达高峰后,一直维持在稳定状

基金:国自然申请中的“科学问题”和“关键问题”

先来说个故事:某校领导拿了几份当年没有获得批准的申请书去国家基金委相关处室“请教”这几项为什么没有批准,希望多了解一点同行的意见,提高学校国家基金项目的命中率。基金委相关处室领导认真查阅了这几份申请书的同行评审意见,说“你们这个研究基础确实较好,对于选题的调研分析也还到位。但关键问题是缺乏对国内外同行研究状况的评述,要让评审人看到选题确实是建立在同行研究的基金上”。所以,认真调研同行的研究状况固然

中医药领域启动国家自然科学基金重大项目

16日,由成都中医药大学梁繁荣教授主持的国家自然科学基金“十二五”重大项目——“穴位的敏化研究”在成都启动,这是中医药领域首个国家自然科学基金重大项目。 据悉,该项目由成都中医药大学牵头,北京中医药大学、复旦大学、中国人民解放军第四军医大学、四川大学联合承担,是中医药领域首个获得立项资助的国家自然科学基金重大项目。项目研究目标是揭示穴位敏化在不同病症发生、发展、转归的时空动态规律,为